BUZZ - Summit shares soar after AstraZeneca injects $2 billions
路透社2026/09/28 22:01September 28 - ** Summit Therapeutics (SMMT.O) shares rose 18% in after-hours trading, closing at $18.2
** AstraZeneca (AZN.L) will invest $2 billion in Summit Therapeutics through convertible preferred stock
** The investment can reportedly be converted to common stock at $18.36 per share, a premium over the day's closing price
** The company reached a clinical collaboration with AstraZeneca to evaluate the efficacy of ivonescimab combined with AstraZeneca's sonesitatug vedotin in the treatment of gastrointestinal cancer
** The company said it plans to assess the combined efficacy of ivonescimab with other AstraZeneca cancer drugs, including antibody-drug conjugates
** The company stated that AstraZeneca's investment is expected to be completed by the end of this week, subject to customary conditions
** As of the previous trading day's close, SMMT had fallen 11.5% year-to-date
(To facilitate non-native English speakers, Reuters provides its reports automatically translated into several other languages. As automated translation may contain errors or lack needed context, Reuters does not guarantee the accuracy of this automated translation and provides it solely for readers’ convenience. Reuters accepts no responsibility for any harm or loss arising from use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rare in 25 years! The 10-year U.S. Treasury yield surpasses the S&P 500 earnings yield
The 10-year US Treasury yield has surpassed 5%, making bonds more attractive relative to stocks than at any point in the past 25 years. The earnings yield of stocks, as measured by the inverse of the S&P 500’s price-to-earnings ratio, is now lower than the 10-year US Treasury yield, resulting in a clear yield suppression effect on the stock market from bonds. According to the Shiller model, the S&P 500 may outperform bonds by only about 1% annually over the next decade. The 20-year paradigm of stocks outperforming bonds has officially come to an end.
Iron ore retreats, copper takes the lead: Australian mining stocks find a new growth story
Analysts state that the rapid growth in copper demand driven by power infrastructure and artificial intelligence (AI) provides a new rationale for investors to allocate to the mining sector. Australian mining stocks are expected to continue their upward trend.
The IRS May Be Coming for Crypto ETFs Next: Which Funds Are at Risk?
Crypto prices
More
